India, June 3 -- The U.S. Food and Drug Administration announced the launch of Elsa, a generative Artificial Intelligence or AI tool, with a view to modernize agency functions to optimize performance.
Elsa, which is built within a high-security GovCloud environment, offers a secure platform for the FDA employees to access internal documents while ensuring all information remains within the agency. It helps scientists and investigators to improve operational efficiency by spending less time on tedious, repetitive tasks that often slow down the review process.
The FDA said it launched Elsa ahead of schedule using an all-center approach, prioritizing efficiency and responsibility. As Elsa, its initial step in the overall AI journey, matures,...